Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

pruxelutamide (GT0918)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Kintor Pharma

Drug class:

Androgen receptor antagonist, TMPRSS2 inhibitor

Related drugs:

AR positive	Breast Cancer	AR positive	Breast Cancer	GT0918 Sensitive: C2 – Inclusion Criteria GT0918 Sensitive : C2	GT0918 Sensitive: C2 – Inclusion Criteria GT0918 Sensitive : C2
HR positive + AR positive	HER2 Negative Breast Cancer	HR positive + AR positive	HER2 Negative Breast Cancer	fulvestrant + GT0918 Sensitive: C3 – Early Trials fulvestrant + GT0918 Sensitive : C3	fulvestrant + GT0918 Sensitive: C3 – Early Trials fulvestrant + GT0918 Sensitive : C3
AR positive	Prostate Cancer	AR positive	Prostate Cancer	GT0918 Sensitive: D – Preclinical GT0918 Sensitive : D	GT0918 Sensitive: D – Preclinical GT0918 Sensitive : D